This cohort-level memo summarizes 100 distinct genomic variants observed in a non-coding/intronic region on chromosome 1. The headline finding is a strongly benign background: 87/100 variants are classified as Benign and 2/100 as Likely benign, with no Pathogenic or Likely pathogenic variants identified. The remaining 11 variants are classified as of Uncertain significance (VUS), largely reflecting rarity and limited functional information in this non-coding context.

## Cohort statistics

**Cohort size and annotation coverage**

- Total variants: 100  
- Unannotated (no external database hit / limited consequence info): 7  

**ACMG/AMP-style classification distribution (precomputed)**

- Benign: 87  
- Likely benign: 2  
- Uncertain significance (VUS): 11  
- Pathogenic / Likely pathogenic: 0  

This pattern indicates a predominantly benign variant landscape, typical of a common polymorphism-rich non-coding region, with a modest VUS burden driven by rarity rather than strong pathogenic evidence.

**ClinVar significance profile (from MyVariant.info)**

- ClinVar significance counts:  
  - “not provided”: 100  

None of the variants have a reported, curated clinical significance call in ClinVar. All appear either unsubmitted or lack assertion-level data in ClinVar at the time of annotation. As a result, this memo relies entirely on population frequency and predicted consequence-based ACMG/AMP heuristics, rather than clinical case evidence.

**Most severe functional consequences (from Ensembl VEP)**

Precomputed counts for the most severe consequence per variant:

- non_coding_transcript_exon_variant: 55  
- intron_variant: 41  
- splice_region_variant: 1  
- splice_donor_5th_base_variant: 1  

Overall, the region is dominated by:

- Variants in non-coding exons of transcripts (55%)  
- Pure intronic variants (41%)  
- Only 2 variants near canonical splice elements (one in a splice region, one at the splice donor +5 base), both very common and classified as Benign.

No protein-coding consequences (missense, nonsense, frameshift, canonical splice site) are present in the summary, consistent with the locus being in non-coding / intronic sequence relative to the transcripts consulted.

**Allele-frequency profile (from gnomAD via MyVariant.info)**

- Variants with any gnomAD AF reported: 92/100  
- Rare variants (AF < 1×10⁻⁴): 1  
- Common variants (AF > 5%): 87  
- AF range (across variants with AF):  
  - Minimum: 0.0  
  - Median: 0.745112  
  - Maximum: 1.0  

Key observations:

- The median AF (~0.75) indicates that most variants are common polymorphisms.  
- 87% of variants fall into a “common >5%” category, which strongly supports the use of BA1 (“benign based on high population frequency”) as the primary classification criterion.  
- Only one variant meets the rarity threshold (<1×10⁻⁴). Several additional variants have low but non-ultra-rare AF in the 0.3–2% range, but these are still far from rare disease-associated frequencies.

**Notable-variant summary (from the precomputed `summary`)**

- Notable variant count: 0  
- Notable variants list: empty  

The engine did not flag any variant as “notable” under its heuristic (typically reserved for Pathogenic/Likely pathogenic or particularly interesting borderline calls). Accordingly, the detailed “Notable variants” section below focuses on explaining why common variants are treated as benign and how the VUS calls arise, rather than highlighting high-risk alleles.

## Notable variants

Although the summary reports no Pathogenic or Likely pathogenic calls, several variants illustrate important principles:

### 1. Benign calls driven by very high population frequency (BA1)

Many variants in this cohort, such as:

- chr1:g.783175T>C (AF 0.999895; non_coding_transcript_exon_variant; Benign, BA1)  
- chr1:g.784860T>C (AF 0.975199; non_coding_transcript_exon_variant; Benign, BA1)  
- chr1:g.840046G>A (AF 0.994416; intron_variant; Benign, BA1)  
- chr1:g.884537A>G (AF 1.0; intron_variant; Benign, BA1)  
- chr1:g.886507A>G (AF 0.999921; intron_variant; Benign, BA1)

are present at ~100% or near-fixation in gnomAD populations.

Interpretation points:

- Variants with AF approaching or equal to 1.0 are effectively the reference allele in the sampled populations; treating them as pathogenic would contradict basic disease genetics assumptions (a fully penetrant, severe Mendelian allele cannot be fixed in the general population).  
- BA1 is appropriately applied here: a very high population frequency, with no supporting disease evidence, justifies a Benign classification under ACMG/AMP guidance.  
- Their consequences are intronic or non-coding, providing an additional layer of plausibility for benign impact (though frequency alone is generally sufficient for BA1).

These examples highlight how population databases like gnomAD are central to ruling out pathogenicity for common non-coding variants.

### 2. Common variants near splice motifs, still classified as Benign

Two variants have more splice-related consequences:

- chr1:g.827252T>A  
  - Consequence: splice_region_variant  
  - AF: 0.748744  
  - Classification: Benign (BA1)  

- chr1:g.852019G>T  
  - Consequence: splice_donor_5th_base_variant (position +5, outside the canonical ±1–2)  
  - AF: 0.681338  
  - Classification: Benign (BA1)  

Interpretation points:

- Despite being proximal to splice sites, their high AF (>68%) in the general population argues strongly against a deleterious effect on gene function.  
- ACMG/AMP generally treats common variants near splice sites as benign unless strong functional evidence suggests otherwise.  
- These examples illustrate that consequence terms alone (e.g., “splice_region_variant”) are not sufficient for pathogenic classification; they must be considered together with AF and functional data.

### 3. Likely benign variants with moderately elevated allele frequencies (BS1)

Two variants are called Likely benign:

- chr1:g.797392G>A  
  - AF: 0.01222  
  - Consequence: intron_variant  
  - Classification: Likely benign (BS1)  

- chr1:g.857700A>G  
  - AF: 0.0343777  
  - Consequence: non_coding_transcript_exon_variant  
  - Classification: Likely benign (BS1)  

Interpretation points:

- Both have AFs in the 1–3% range. These are not ultra-rare; with no strong disease evidence or functional impact, their population frequency supports BS1 (allele frequency too high for a severe disease allele) rather than BA1.  
- Because their AF is lower than the very high “BA1” threshold, the engine conservatively labels them Likely benign rather than definitively Benign.  
- This illustrates a gradient: as AF decreases, the confidence in benignity is somewhat reduced, even though these frequencies remain inconsistent with most Mendelian disease models.

### 4. VUS variants driven by rarity and/or lack of annotation (PM2)

Several variants are classified as VUS with PM2 (absent or nearly absent from population databases):

- chr1:g.805514AC>A (found=false; AF null; consequence null; VUS, PM2)  
- chr1:g.814583T>TAA (found=false; AF null; intron_variant; VUS, PM2)  
- chr1:g.814682A>AG (found=false; AF null; intron_variant; VUS, PM2)  
- chr1:g.842922C>CCT (found=false; AF null; non_coding_transcript_exon_variant; VUS, PM2)  
- chr1:g.855316C>CAT (found=false; AF null; non_coding_transcript_exon_variant; VUS, PM2)  
- chr1:g.855378GTA>G (found=false; AF null; consequence null; VUS, PM2)  
- chr1:g.886224T>TGCCCTTTGGCAGAGCAGGTGTGCTGTGCTG (found=false; AF null; intron_variant; VUS, PM2)  

Interpretation points:

- “found=false” and AF=null indicate that these variants could not be matched to entries in gnomAD or ClinVar using the query schema in this pipeline, and thus lack population frequency information.  
- PM2 alone (“absent from controls”) is not sufficient to declare pathogenicity, especially in non-coding/intronic regions without functional assays or conservation data.  
- Consequently, these are conservatively labeled VUS: they are rare or unobserved, but there is no strong evidence in either direction regarding pathogenicity.

Additional VUS variants include:

- chr1:g.807445A>G (AF 0.00444915; non_coding_transcript_exon_variant; VUS, no explicit criteria)  
- chr1:g.852047C>T (AF 0.00346469; non_coding_transcript_exon_variant; VUS, no explicit criteria)  
- chr1:g.853663G>C (AF null; non_coding_transcript_exon_variant; VUS, PM2)  
- chr1:g.853670G>A (AF 0.0; non_coding_transcript_exon_variant; VUS, PM2)

Interpretation points:

- AFs in the ~0.3–0.4% range (0.003–0.004) are low enough that these variants are not common polymorphisms, but still present in gnomAD; in the absence of strong functional or disease evidence, they remain VUS.  
- chr1:g.853670G>A with AF=0.0 is treated similarly to an “absent” variant, carrying PM2. AF=0.0 may reflect rounding or limited sampling, but from this pipeline’s perspective it behaves like “not observed in controls.”

No VUS in this dataset is supported by additional pathogenic criteria (e.g., PS, PVS), underscoring that these are cautious “unknown” calls rather than early-pathogenic candidates.

## Patterns & caveats

**1. Strongly benign background with limited clinical annotation**

- 87% Benign and 2% Likely benign classifications signal that this locus is saturated with common polymorphisms, many near fixation.  
- All 100 variants are “ClinVar: not provided”, meaning this region is not widely represented in ClinVar submissions, or submissions lack assertion data.  
- The classification engine therefore relies heavily on population frequency (BA1/BS1) and basic consequence terms, which is appropriate for an educational, heuristic pipeline but limited in clinical granularity.

**2. VUS burden primarily reflects lack of data, not suspected pathogenicity**

- 11 variants are VUS; most are rare/absent in gnomAD or structurally unusual (small indels such as chr1:g.805514AC>A, chr1:g.855316C>CAT, or the longer insertion at chr1:g.886224T>…).  
- These variants occur in a non-coding/intronic setting without functional or segregation data included, and thus cannot be confidently classified.  
- In a clinical setting, many of these might ultimately prove benign (if functional assays or family studies show no effect), but with current information they remain “unknown”.

**3. Non-coding context limits interpretation power**

- All consequences are intron_variant, non_coding_transcript_exon_variant, or mild splice-related categories (splice_region; splice_donor_5th_base).  
- No canonical splice (±1–2) or coding variants are present, which reduces the chance of high-impact alleles but also makes inference harder—non-coding regulatory effects are more subtle and less well captured by simple consequence terms.  
- In practice, pathogenicity in non-coding regions often requires detailed functional characterization (e.g., reporter assays, RNA-seq), which is beyond this pipeline.

**4. Allele-frequency-driven benign calls are appropriate but not infallible**

- The heavy reliance on BA1/BS1 mirrors ACMG/AMP’s strong weighting of population data: extremely common alleles cannot be fully penetrant Mendelian disease variants.  
- However, this does not exclude nuanced roles such as:  
  - Very mild or late-onset effects  
  - Polygenic or complex-disease risk modifiers  
- The pipeline does not attempt to capture such subtle associations; all common variants are simply labeled Benign or Likely benign.

**5. Unannotated variants and structural changes**

- 7 variants are flagged as “unannotated” in the summary (and several show “found=false” with AF=null and limited VEP consequence detail).  
- Some of these involve small or larger insertions (e.g., chr1:g.886224T>… long insertion), which can be more difficult to reconcile across databases due to representation differences (e.g., left-alignment, HGVS vs. VCF).  
- Their VUS classifications are therefore partly driven by technical limitations in cross-database matching, rather than an evidence-based suspicion of pathogenicity.

Overall, the pattern is a benign, common-polymorphism-rich non-coding region with a small tail of rare, structurally diverse VUS, none of which currently carry strong evidence for disease relevance in this pipeline.

## Data sources

This memo is based entirely on the precomputed annotations and classifications in the provided JSON, which in turn draw from:

- **MyVariant.info** for integrative variant-level annotation, including:  
  - **ClinVar**: clinical significance and review status (here uniformly “not provided”)  
  - **gnomAD**: population allele frequencies across diverse cohorts  

- **Ensembl Variant Effect Predictor (VEP)** for transcript-level consequences, including:  
  - non_coding_transcript_exon_variant  
  - intron_variant  
  - splice_region_variant  
  - splice_donor_5th_base_variant  

The ACMG/AMP-style classifications (Benign, Likely benign, VUS) and the associated criteria (e.g., BA1, BS1, PM2) were produced by a simplified, deterministic rules engine upstream of this memo and have not been modified or recomputed here.

> **DISCLAIMER -- RESEARCH / EDUCATION ONLY. NOT FOR CLINICAL USE.** This memo was generated by an automated teaching pipeline using a simplified ACMG/AMP heuristic subset and must not be used to diagnose, treat, or make any medical decision. Clinical interpretation requires a qualified molecular geneticist in an accredited (CAP/CLIA) laboratory.